Q32 Bio (QTTB) SIGNAL-AD trial did not achieve its primary endpoint, SIGNAL-AA demonstrated encouraging clinical activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. META
3. NVDA
4. DCOY
5. SPY
6. MSFT
7. VKTX
8. PRGS
9. CMPX
10. GS

Go back to Q32 Bio (QTTB) SIGNAL-AD trial did not achieve its primary endpoint, SIGNAL-AA demonstrated encouraging clinical activity
(NASDAQ: QTTB) Delayed: 10.57 +0.10 (0.96%)
Previous Close $10.47    52 Week High $ 
Open $10.60    52 Week Low $ 
Day High $10.99    P/E N/A 
Day Low $10.53    EPS $ 
Volume 387,173